vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and PCB BANCORP (PCB). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $29.2M, roughly 1.1× PCB BANCORP). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs -4.5%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $25.0K). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
LFCR vs PCB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $29.2M |
| Net Profit | $-10.0M | — |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 45.0% |
| Net Margin | -32.1% | — |
| Revenue YoY | -4.5% | 11.3% |
| Net Profit YoY | -52.0% | — |
| EPS (diluted) | $-0.29 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $29.2M | ||
| Q3 25 | $31.1M | $30.4M | ||
| Q2 25 | — | $29.3M | ||
| Q1 25 | $35.2M | $26.9M | ||
| Q4 24 | $32.6M | $26.2M | ||
| Q3 24 | $24.7M | $25.3M | ||
| Q2 24 | — | $24.2M | ||
| Q1 24 | $35.7M | $23.9M |
| Q4 25 | — | — | ||
| Q3 25 | $-10.0M | $11.4M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | $-14.8M | $7.7M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-16.2M | $7.8M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | $15.6M | $4.7M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 45.0% | ||
| Q3 25 | -9.9% | 52.3% | ||
| Q2 25 | — | 43.3% | ||
| Q1 25 | -25.7% | 40.2% | ||
| Q4 24 | -6.0% | 39.3% | ||
| Q3 24 | -46.9% | 42.2% | ||
| Q2 24 | — | 36.3% | ||
| Q1 24 | -2.5% | 27.2% |
| Q4 25 | — | — | ||
| Q3 25 | -32.1% | 37.5% | ||
| Q2 25 | — | 31.0% | ||
| Q1 25 | -42.0% | 28.8% | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -65.7% | 30.8% | ||
| Q2 24 | — | 25.9% | ||
| Q1 24 | 43.8% | 19.6% |
| Q4 25 | — | $0.65 | ||
| Q3 25 | $-0.29 | $0.78 | ||
| Q2 25 | — | $0.62 | ||
| Q1 25 | $-0.47 | $0.53 | ||
| Q4 24 | $-0.25 | $0.46 | ||
| Q3 24 | $-0.53 | $0.52 | ||
| Q2 24 | — | $0.43 | ||
| Q1 24 | $0.42 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $207.1M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $390.0M |
| Total Assets | $235.2M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $207.1M | ||
| Q3 25 | $18.9M | $369.5M | ||
| Q2 25 | — | $263.6M | ||
| Q1 25 | $5.4M | $214.3M | ||
| Q4 24 | $9.5M | $198.8M | ||
| Q3 24 | — | $193.1M | ||
| Q2 24 | — | $177.6M | ||
| Q1 24 | — | $239.8M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $390.0M | ||
| Q3 25 | $-10.5M | $384.5M | ||
| Q2 25 | — | $376.5M | ||
| Q1 25 | $2.2M | $370.9M | ||
| Q4 24 | $15.4M | $363.8M | ||
| Q3 24 | $-3.9M | $362.3M | ||
| Q2 24 | — | $353.5M | ||
| Q1 24 | $17.7M | $350.0M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | $235.2M | $3.4B | ||
| Q2 25 | — | $3.3B | ||
| Q1 25 | $237.7M | $3.2B | ||
| Q4 24 | $255.4M | $3.1B | ||
| Q3 24 | $246.8M | $2.9B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | $246.2M | $2.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $26.6M |
| Free Cash FlowOCF − Capex | $25.0K | $24.4M |
| FCF MarginFCF / Revenue | 0.1% | 83.6% |
| Capex IntensityCapex / Revenue | 5.6% | 7.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.6M | ||
| Q3 25 | $1.8M | $16.4M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | $1.2M | $2.3M | ||
| Q4 24 | $-6.1M | $39.0M | ||
| Q3 24 | $-613.0K | $11.9M | ||
| Q2 24 | — | $14.6M | ||
| Q1 24 | $-1.4M | $8.2M |
| Q4 25 | — | $24.4M | ||
| Q3 25 | $25.0K | $16.2M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | $-4.3M | $1.6M | ||
| Q4 24 | $-8.6M | $34.9M | ||
| Q3 24 | $-4.0M | $11.9M | ||
| Q2 24 | — | $12.8M | ||
| Q1 24 | $-7.8M | $6.0M |
| Q4 25 | — | 83.6% | ||
| Q3 25 | 0.1% | 53.2% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | -12.1% | 6.0% | ||
| Q4 24 | -26.3% | 133.2% | ||
| Q3 24 | -16.3% | 46.8% | ||
| Q2 24 | — | 53.1% | ||
| Q1 24 | -21.8% | 25.2% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | 5.6% | 0.8% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | 15.5% | 2.8% | ||
| Q4 24 | 7.5% | 15.5% | ||
| Q3 24 | 13.9% | 0.1% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | 17.8% | 9.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.33× | ||
| Q1 24 | -0.09× | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
PCB
Segment breakdown not available.
